TGFB1 and Hepatic fibrosis: Thus, the current study provides first-hand clue in vivo evidence that DPx ameliorates hepatic fibrosis by inhibiting TGF-β1/Smad3 and MAPK signaling pathways in hepatocytes of mice administered TAA to induce liver fibrosis.